The Association of Cancer Physicians

... representing and supporting Medical Oncologists in the UK

  • Increase font size
  • Default font size
  • Decrease font size
Media Centre

Report on SACT 30-day mortality published

Email Print

The ACP was pleased to see publication by Public Health England (PHE) of the report in the Lancet Oncology on 30-day mortality following administration of SACT (Systemic Anti-Cancer Therapy) for breast and lung cancers. The data from individual trusts is also available. This is an important marker for safety of the administration of SACT and is one of the measurement used to monitor service quality. These data allow cancer centres to compare and benchmark best practice to ensure continued improvement in services. Over time the accuracy of these reports improves as data collection becomes embedded in good practice, as we have seen with the National Lung Cancer Audit. Ongoing support of these audits by NHS England and individual trusts is essential in maintaining and enhancing the quality of cancer care.

The ACP Chair, Professor Johnathan Joffe has released a statement reflecting on the significance of the data.

Last Updated on Saturday, 03 September 2016 10:57  

Twitter Feed